Vaccine Information: GARDASIL 9 (Page 8 of 8)
PRINCIPAL DISPLAY PANEL — 0.5 mL Vial Carton
NDC 0006-4119-03
10 Single-dose 0.5-mL Vials
REFRIGERATE
Human Papillomavirus 9-valent Vaccine, Recombinant
GARDASIL® 9
Suspension for intramuscular injection
Each 0.5-mL dose contains human papillomavirus L1 protein of each type adsorbed on amorphous aluminum
hydroxyphosphate sulfate adjuvant as follows:
Type 6 (30 mcg), Type 11 (40 mcg), Type 16 (60 mcg), Type 18 (40 mcg), Type 31 (20 mcg), Type 33 (20 mcg),
Type 45 (20 mcg), Type 52 (20 mcg), Type 58 (20 mcg).
Vaccine is prepared from fermentation cultures of a recombinant strain of yeast Saccharomyces cerevisiae containing the genes for the human papillomavirus L1 protein of each type (6, 11, 16, 18, 31, 33, 45, 52, 58).
Contains no preservative or antibiotics.
Rx only
PRINCIPAL DISPLAY PANEL — 0.5 mL Syringe Carton
NDC 0006-4121-02
10 Single-dose 0.5-mL Syringes
REFRIGERATE
Human Papillomavirus 9-valent Vaccine, Recombinant
GARDASIL® 9
Suspension for intramuscular injection
Each 0.5-mL dose contains human papillomavirus L1 protein of each type
adsorbed on amorphous aluminum hydroxyphosphate sulfate adjuvant
as follows:
Type 6 (30 mcg), Type 11 (40 mcg), Type 16 (60 mcg), Type 18 (40 mcg),
Type 31 (20 mcg), Type 33 (20 mcg), Type 45 (20 mcg), Type 52 (20 mcg),
Type 58 (20 mcg).
Vaccine is prepared from fermentation cultures of a recombinant strain of yeast
Saccharomyces cerevisiae containing the genes for the human papillomavirusL1 protein of each type (6, 11, 16, 18, 31, 33, 45, 52, 58).
Contains no preservative or antibiotics.
Rx only
GARDASIL 9 human papillomavirus 9-valent vaccine, recombinant injection, suspension | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
GARDASIL 9 human papillomavirus 9-valent vaccine, recombinant injection, suspension | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
|
Labeler — Merck Sharp & Dohme LLC (118446553) |
Revised: 04/2023 Merck Sharp & Dohme LLC
VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.